Seminars in Oncology
Volume 30, Issue 2 , Pages 153-155 , April 2003

14q32 Translocations discriminate IgM multiple myeloma from Waldenstrom's macroglobulinemia

References 

  1. Waldenström J. Incipient myelomatosis or essential hyperglobulinemia with fibrinogenopenia: A new syndrome?. Acta Med Scand. 1944;117:217–247
  2. Waldenström JG. Macroglobulinemia: A review. Haematologica. 1986;71:437–440
  3. Dimopoulos MA, Panayiotidis P, Moulopoulos LA, et al.  Waldenström's macroglobulinemia: Clinical features, complications, and management. J Clin Oncol. 2000;18:214–226
  4. Creyssel MMR, Charvillat L, Morel P, et al.  Contribution à l'étude biochimique du myélome multiple et des dysprotéinémies malignes. Rev Lyon Med. 1956;5:129–171
  5. Raynaud R, Brochier M, Griguer P, et al.  Sur un cas de dysglobulinémie maligne hémorragipare associant maladie de Kahler et macroglobulinémie. Sang. 1959;30:822–828
  6. Adner L, Wallenius G, Werner I. Macroglobulinemia and myelomatosis. Acta Med Scand. 1960;168:431–437
  7. Marchal G, Fine JM, Bilski-Pasquier G. Macroglobulinémie dans un cas de leucose plasmocytaire. Presse Med. 1962;70:425–428
  8. Bureau Y, Senelar R, Barriere H, et al.  Macroglobulinemia during a case of Kahler's disease. Presse Med. 1968;76:961–964
  9. Welton J, Walker SR, Sharp GC, et al.  Macroglobulinemia with bone destruction. Am J Med. 1968;44:280–288
  10. Okubo H, Shibata K, Kosaka K, et al.  Clinically macroglobulinemia occurring in plasmacytoma and review of literature. Nippon Ketsueki Gakkai Zasshi. 1971;34:622–643
  11. Castleman B, Scully RE, McNeely BU. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 31-1972. N Engl J Med. 1972;287:243–248
  12. Ikeda Y, Ota H, Takenaka T, et al.  A case of primary macroglobulinemia with punched out bone lesions. Rinsho Ketsueki. 1972;13:864–872
  13. Vermess M, Pearson KD, Einstein AB, et al.  Osseous manifestations of Waldenstrom's macroglobulinemia. Radiology. 1972;102:497–504
  14. Goto N, Kurihara T, Asakura Y, et al.  A case of IgM type myeloma. J Jpn Cancer. 1973;9:364–367
  15. Bachman R. The diagnostic significance of the serum concentration of pathological proteins (M-components). Acta Med Scand. 1975;178:801–808
  16. Berman HH. Waldenström's macroglobulinemia with lytic osseous lesions and plasma cell morphology. Am J Clin Pathol. 1975;63:397–402
  17. Kawano K, Takenaka M, Kuwashima M, et al.  Two cases of macroglobulinemia associated with punched-out bone lesions and neoplastic proliferation of plasma cells. Rinsho Ketsueki. 1975;16:820–827
  18. Stein RS, Ellman L, Bloch KJ. The clinical correlates of IgM M-components: An analysis of thirty-four patients. Am J Med Sci. 1975;269:209–216
  19. Fagiolo E. Plasmocytoma with IgM paraproteinemia. A case report. Acta Haematol. 1976;55:123–128
  20. Roujeau JC, Bisson M, Segond P, et al.  Myélome à IgM. Sem Hop Paris. 1976;23:2277–2282
  21. Tubbs RR, Hoffman GC, Deodhar SD, et al.  IgM monoclonal gammopathy. Histopathologic and clinical spectrum. Cleve Clin Q. 1976;43:217–235
  22. Leb L, Grimes ET, Balogh K, et al.  Monoclonal macroglobulinemia with osteolytic lesions: A case report and review of the literature. Cancer. 1977;39:227–231
  23. Fagiolo E, Tosato G. IgM plasmacytoma. Report of a case and review of the literature. Haematologia (Budap). 1978;12:221–229
  24. Fudenberg HH, Virella G. Multiple myeloma and Waldenstrom macroglobulinemia: Unusual presentations. Semin Hematol. 1980;17:63–79
  25. Tsutsumi H, Nakura H, Nakayama M, et al.  A case of IgM type myeloma with pyroglobulinemia. J Jpn Soc Res. 1981;21:271–280
  26. Zarrabi MH, Stark RS, Kane P, et al.  IgM myeloma, a distinct entity in the spectrum of B-cell neoplasia. Am J Clin Pathol. 1981;75:1–10
  27. Takahashi K, Yamamura F, Motoyama H. IgM myeloma: Its distinction from Waldenstrom's macroglobulinemia. Acta Pathol Jpn. 1986;36:1553–1563
  28. De Gramont A, Grosbois B, Michaux JL, et al.  IgM myeloma: 6 cases and a review of the literature. Rev Med Interne. 1990;11:13–18
  29. Haghighi B, Yanagihara R, Cornbleet PJ. IgM myeloma: Case report with immunophenotypic profile. Am J Hematol. 1998;59:302–308
  30. Dierlamm T, Laack E, Dierlamm J, et al.  IgM myeloma: A report of four cases. Ann Hematol. 2002;81:136–139
  31. Avet-Loiseau H, Facon T, Grosbois B, et al.  Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features and clinical presentation. Blood. 2002;99:2185–2191
  32. Juge-Morineau N, Heirman C, Bakkus M, et al.  Immunoglobulins D and M multiple myeloma variants are heavily mutated. Clin Cancer Res. 1997;3:2501–2506
  33. Sahota SS, Garand R, Mahroof R, et al.  V(H) gene analysis of IgM-secreting myeloma indicates an origin from a memory cell undergoing isotype switch events. Blood. 1999;94:1070–1076
  34. Avet-Loiseau H, Garand R, Lode L, et al.  Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants. Blood. 2003;101:1570–1571

☆ Address reprint requests to Hervé Avet-Loiseau, Laboratoire d'Hematologi, Institut de Biologie, 9, quai Moncousu, 44093 Nantes Cedx 1, France.

☆☆ 0093-7754/03/3002-0018$30.00/0

PII: S0093-7754(03)70067-0

doi: 10.1053/sonc.2003.50053

Seminars in Oncology
Volume 30, Issue 2 , Pages 153-155 , April 2003

Article Tools